Pion radiation for high grade astrocytoma: Results of a randomized study

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 491-497

  Pickles, Tom ^a   Goodman, George B ^a   Rheaume, Dorianne E ^a   Duncan, Graeme G ^a   Fryer, Chris J ^a   Bhimji, Shamim ^a   Ludgate, Charles ^a   Syndikus, Isabel ^a   Graham, Peter ^a   Dimitrov, Mario ^a   Bowen, Julie ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Astrocytoma; Clinical trial Phase 3; Particle therapy; Pions; Quality of life; Radiotherapy

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; NEGATIVE PION RADIATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION SICKNESS; STATISTICAL ANALYSIS;

ADULT; AGED; BRAIN NEOPLASMS; CAUSE OF DEATH; GLIOBLASTOMA; HUMANS; MESONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PHOTONS; QUALITY OF LIFE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 17144468200     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00542-1     Document Type: Article

References (25)

1. Bleehen, N. M.; Stenning, S. P. A Medical Research Council trial of two radiotherapy doses in the treatment of Grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br. J. Cancer 64:769-774; 1991.
2. Catterall, M.; Bloom, H. J.; Ash, D. V.; Walsh, L.; Richardson, A.; Uttley, D.; Gowing, N. F.; Lewis, P.; Chaucer, B. Fast neutrons compared with megavoltage X rays in the treatment of patients with supratentorial glioblastomas: A controlled pilot study. Int. J. Radiat. Oncol. Biol. Phys. 6:261-266; 1980.
3. Daumas-Duport, C.; Scheithauer, B.; O'Fallon, J.; Kelly, P. Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152-2165; 1988.
4. Duncan, W. An evaluation of the results of neutron therapy trials. Acta Oncol. 33:299-306; 1994.
5. Duncan, W.; McLelland, J.; Jack, W. J.; Arnott, S. J.; Gordon, A.; Kerr, G. R.; Williams, J. R. Reports of a randomized pilot study of the treatment of patients with supra-tentorial gliomas using neutron irradiation. Br. J. Radiol. 59:373-377; 1986.
6. Duncan, W.; McLelland, J.; Jack, W. J.; Arnott, S. J.; Davey, P.; Gordon, A.; Kerr, G. R.; Williams, J. R. The results of a randomized trial of mixed schedule (neutron/photon) irradiation in the treatment of supra-tentorial Grade III and IV astrocytoma. Br. J. Radiol. 59:379-383; 1986.
7. EORTC Brain Tumor Group. Misonidazole in radiotherapy of supratentorial malignant gliomas in adult patients: A randomized double-blind study. Eur. J. Cancer 19:39-42; 1983.
8. Goodman, G. B.; Skarsgard, L. D.; Thompson, G. B.; Harrison, R.; Lam, G. K. Y.; Ludgate, C. Pion therapy at Triumf. Treatment results for astrocytoma Grades 3 and 4: A pilot study. Radiother. Oncol. 17:21-28; 1990.
9. Griffin, T. W.; Davis, R.; Laramore, G.; Hendrickson, F.; Rodrigues-Antunez, A.; Hussey, D.; Nelson, J. Fast neutron radiation therapy for glioblastoma multiforme: Results of a RTOG randomized study. Am. J. Clin. Oncol. 1:661-667; 1983.
10. Horiot, J. C.; van den Bogaert, W.; Ang, K. K.; Van der Schueren, E.; Bartelink, H.; Gonzalez, D.; de Pauw, M.; van Glabbeke, M. European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey. Front. Radiat. Ther. Oncol. 22:149-161; 1988.
11. Kristiansen, K.; Hagen, S.; Kollevold, T.; Torvik, A.; Holme, I.; Nesbakken, R.; Hatlevoll, R.; Lindgren, M.; Brun, A.; Lindgren, S.; Notter, G.; Andersen, A. P.; Eigen, K. Combined modality therapy of operated astrocytomas Grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649-652; 1981.
12. Laramore, G. E.; Diener-West, M.; Griffin, T. W.; Nelson, J. S.; Griem, M. L.; Thomas, F. J.; Hendrickson, F. R.; Griffin, B. R.; Myrianthopoulos, L. C.; Saxton, J. Randomized neutron dose searching study for malignant gliomas of the brain: Results of an RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 14:1093-1102; 1988.
13. Ludgate, C. M.; Douglas, B. G.; Dixon, P. F.; Steinbok, P.; Jackson, S. M.; Goodman, G. B. Superfractionated radiotherapy in Grade III and IV intracranial gliomas. Int. J. Radiat. Oncol. Biol. Phys. 15:1091-1095; 1988.
14. Nelson, D. F.; Nelson, J. S.; Davis, D. R.; Chang, C. H.; Griffin, T. W.; Pajak, T. F. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J. Neurooncol. 3:99-103; 1985.
15. Nelson, J. S.; Tsukada, Y.; Schoenfeld, D.; Fulling, K.; Lamarche, J.; Peress, N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52:550-554; 1983.
16. Ogawa, Y.; Goodman, G. B.; Chaplin, D.; Grulkey, W.; Lam, G. K. Y. The response of mouse tumors to fractionated doses of pions: Determination of therapeutic gain factor. Oncology 48:81-87; 1991.
17. Palcic, B.; Korbelik, M.; Sjkarsgard, L. Oxygen enhancement ratio and split dose-recovery with pion beams. In: Skarsgard, L. D., ed. Pion and heavy ion radiotherapy. New York: Elsevier; 1982.
18. Pickles, T.; Bowen, J.; Dixon, P.; Gaffney, C.; Pomeroy, M.; Rheaume, D.; Vernimmen, F.; Goodman, G. Pions: The potential for therapeutic gain in locally advanced prostate cancer. Dose escalation and toxicity studies from TRIUMF. Int. J. Radiat. Oncol. Biol. Phys. 21:1005-1011; 1991.
19. Pickles, T.; Goodman, G. B.; Syndikus, I.; Graham, P.; Dimitrov, M.; Bowen, J.; Morris, J.; McKenzie, M.; Duncan, G. G.; Rheaume, D. An analysis of acute and late toxicity in a randomized study of pion vs. photon irradiation for stage T3/4 prostate cancer. Abstracts of the XXIX Proton Therapy Cooperative Group Meeting, Detroit, April 1996.
20. Rampling, R.; Cruickshank, G. Direct measurement of the PO2 distribution and bioreductive enzymes in human malignant brain tumours. Int. J. Radiat. Oncol. Biol. Phys. 29:427-431; 1994.
21. Scanlon, P. W.; Taylor, W. F. Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery 5:301-308; 1979.
22. Schwarz, R.; Krull, A.; Heyer, D.; Baumann, M.; Schmidt, R.; Hubener, K. Present results of neutron therapy: The German experience. Acta Oncol. 33:281-287; 1994.
23. Walker, M. D.; Green, S. B.; Byar, D. P.; Alexander, E., Jr.; Batzdorf, U.; Brooks, W. H.; Hunt, W. E.; MacCarty, C. S.; Mahaley, M. S., Jr.; Mealey, J., Jr.; Owens, G.; Ransohoff, J., Jr.; Robertson, J. T.; Shapiro, W. R.; Smith, K. R., Jr.; Wilson, C. B.; Strike, T. A. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303:1323-1329; 1980.
24. Webb, S. The physics of proton radiotherapy. In: The physics of three dimensional radiation therapy: Conformal radiotherapy, radiosurgery, and treatment planning. Philadelphia: Institute of Physics; 1993.
25. Wood, J. R.; Green, S. B.; Shapiro, W. R. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J. Clin. Oncol. 6:338-343; 1988.